Helios
Founded in 2015, Helios Global Group is a full-service healthcare communications group working with some of the world’s leading pharmaceutical and biotech companies. Supporting clients within the medical affairs, commercial and market access functions, the group provides strategic consultancy, medical and scientific communications, and commercialisation solutions. Headquartered in Alderley Edge, Cheshire with further UK offices in Oxford, Manchester and Cambridge, alongside an expanding US base in Connecticut, Helios employs almost 300 healthcare communications and market access/HEOR professionals.
“During our investment process, we were deeply impressed by the Jacobs Capital team’s entrepreneurial drive and genuine enthusiasm, underpinned by their thoughtful and professional approach. Since becoming our partners, they have consistently demonstrated their strategic agility and deep sector expertise, challenging our thinking constructively while providing strong support for our vision to grow and develop the business.”
Andrew Minnock,
CEO of Helios Global